The early stage company is developing a new approach to gene editing to treat rare genetic diseases. It does this using mRNA, ...

HHS said Moderna will develop and assess an mRNA vaccine against H7N9 avian influenza in a phase ... patients benefitted from Paxlovid when administered within 5 days of COVID-19 infection ...